BREAKING
Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago
ADVERTISEMENT
AlphaGraphs

Merck (MRK) Earnings: 3Q23 Key Numbers

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year ago. GAAP net income increased 46% to $4.7 billion, or $1.86 per share, compared to last year. Adjusted EPS rose 15% to $2.13. For the full year of 2023, the company expects worldwide […]

$MRK October 27, 2023 1 min read
NYSE
$MRK · Earnings

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year ago. GAAP net income increased 46% to $4.7 billion, or $1.86 per share, compared to last year. Adjusted EPS rose 15% to $2.13. For the full year of 2023, the company expects worldwide […]

· October 27, 2023

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year ago.

GAAP net income increased 46% to $4.7 billion, or $1.86 per share, compared to last year. Adjusted EPS rose 15% to $2.13.

For the full year of 2023, the company expects worldwide sales to be $59.7-60.2 billion and adjusted EPS to be $1.33-1.38.

Prior performance

ADVERTISEMENT